Chinese patients will be able to get a second opinion from U.S. medical organizations later this year after a new service is added to the online Citizen Health Platform of Shenzhen, operated by Hong Kong-based Good Health System Group and the Hong Kong Institute of Cell Molecular Medicine (ICMM). Patients will be able to upload their medical records and examination reports and have them translated into English by doctors in Hong Kong or Singapore. They will receive a diagnostic report issued by international teaching hospitals or institutions in the United States within two weeks. So far, four American medical institutions – United Healthcare, Mayo Clinic, UCSF Medical Center and Memorial Sloan Kettering Cancer Center – will collaborate with ICMM for the project. More are expected to sign up in the near future, said Dr. Jiang Zhongyuan, founder of ICMM. “In Hong Kong and overseas, many people seek a second opinion to confirm a diagnosis of cancer or other critical illness,” Jiang said. This could also push Chinese patients to seek follow-up treatment overseas, which could reduce the workload for doctors at busy hospitals. Medical tourism is already booming among wealthy Chinese, the South China Morning Post reports.